JAMES PIMENTEL: Open Payments
NPI 1265046379 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 6 payments from 6 companies in 2025. Trend: 2023 $434 · 2024 $386 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $142 |
| Ipsen Biopharmaceuticals, Inc | 1 | $139 |
| Gilead Sciences, Inc. | 1 | $125 |
| Inari Medical, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $15 |
Products named: REZDIFFRA, IQIRVO, Veklury, FLOWTRIEVER CATHETER, S, DALVANCE, GIAPREZA.
Industry payments across NJ — which companies pay providers there.
